Live Breaking News & Updates on Viatris Pharmaceuticals Japan Inc

Stay updated with breaking news from Viatris pharmaceuticals japan inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viatris Named to Forbes' Annual List of the World's Best Employers ...

Viatris Named to Forbes Annual List of the World s Best Employers . ....

United States , Andhra Pradesh , Andrew Enrietti , Jennifer Mauer , Matt Klein , Global Health , News Network , Newsweek America Most Responsible Companies , Viatris Inc , Hr Asia Best Companies To Work , Newsweek America Greenest Companies , World Best Companies , Best Employers , Chief Human Relations Officer , Forbe List , Corporate Citizens , Greenest Companies , Best Companies , United States Today , Climate Leaders , Most Responsible Companies , Great Place , Capital Magazine , Bill Szablewski , Contact Info ,

Viatris president Rajiv Malik to retire in April next year

Malik was instrumental in the $12 billion merger of Mylan with Pfizer s generic drug unit that resulted in the creation of Viatris in 2019. The combined entity s sales are more than that of Israel s Teva, which was previously the largest generic drug company in the world. ....

New Delhi , Robertj Coury , Rajiv Malik , Indian Born Rajiv Malik , Largest Generics Drugmaker , Drug Company ,

Viatris Named to 3BL's 100 Best Corporate Citizens of 2023 Ranking

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced it has been named to 3BL's annual 100 Best Corporate Citizens ranking, recognizing outstanding environmental, social and governance (ESG) transparency and performance among the 1,000 largest U.S. public companies. 3BL is a news distribution platform that promotes ESG initiatives of leading companies and non-profit organizations. ....

Viatris Inc , Global Healthcare Company , Corporate Citizen , Ocial And Governance , Corporate Responsibility , Institutional Shareholder Services ,

Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

LONDON, October 10, 2023 Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc. Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and anti-trust approvals. ....

City Of , United Kingdom , Katja Lundell , Rob Stewart , Viatris Inc , Senior Director , Global Head , Womens Health , Pharmaceutical Company ,

Saraf And Partners, Viatris, Women's Healthcare Business, Active Pharmaceutical Ingredients

Global healthcare leader Viatris, (formerly known as Mylan), has taken a significant step towards its strategic goals by entering into agreements on October 1st to divest key business segments,. ....

Bikash Jhawar , Akshayys Nanda , Alex Koshy , Amit Gupta , Insud Pharma , Mohit Saraf , Lakshay Jain , Firm Founder , India To Iquest Enterprises , Srikari Kancherla Associates , Iquest Enterprises , Managing Partner , Senior Partner Bikash Jhawar , Partner Nipun Vaid , Navomi Koshy , Principal Associate , Srikari Kancherla , Sahil Arora , Foreign Direct Investment , Saraf And Partners , Omens Healthcare Business , Active Pharmaceutical Ingredients ,